Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Clinical trial NCT07668271 · RECRUITING

Trial details

NCT number: NCT07668271
Sponsor: Xiamen Innovax Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Infection by Human Papilloma Virus

Start date: 2026-05-26
Primary completion: 2027-02-28
Enrollment: 720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.